1 documents found
Information × Registration Number 0107U012631, R & D request Title International, multicentered, randomized, double, blind, placebo-controlled, parallel group investigation of efficacy and safety of Kvetiapin Fumarat (Serokvel 1 peroral dose 300mg and 600 mg)and lithium as monotherapy in adults with bipolar depression for 8 weeks of treatment and Kvetiapin for long-term treatment from 26 to 52 weeks Head Кузнецов Валерій Миколайович, Registration Date 27-12-2007 Organization Shupyk National Medical Academy of Postgraduate Education popup.description1 popup.nrat_date 2024-12-10 Close
search.res_rk
International, multicentered, randomized, double, blind, placebo-controlled, parallel group investigation of efficacy and safety of Kvetiapin Fumarat (Serokvel 1 peroral dose 300mg and 600 mg)and lithium as monotherapy in adults with bipolar depression for 8 weeks of treatment and Kvetiapin for long-term treatment from 26 to 52 weeks
Head: Кузнецов Валерій Миколайович. International, multicentered, randomized, double, blind, placebo-controlled, parallel group investigation of efficacy and safety of Kvetiapin Fumarat (Serokvel 1 peroral dose 300mg and 600 mg)and lithium as monotherapy in adults with bipolar depression for 8 weeks of treatment and Kvetiapin for long-term treatment from 26 to 52 weeks. Shupyk National Medical Academy of Postgraduate Education. № 0107U012631
1 documents found

Updated: 2026-03-23


Роздрукувати цю сторінку